Market Research Industry Reports

Bukwang Pharm Co Ltd (003000) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Bukwang PharmCo Ltd (BUKWANG) is a pharmaceutical company which develops pharmaceutical products and new drugs. The companys product portfolio includes levovir, legalon, dexid, thioctacid, lonasen, ixel, Orfil, azeptin, asima among others. Its pipeline products comprise MLR-1023, JM-010, JM-012 and SOL-804. BUKWANG offers its products in the therapeutic areas of Liver disease, Diabetes, Central Nervous System (CNS) disorders, Respiratory diseases, Prostate cancer, Parkinsons disease and others. The company also offers services such as clinical development, regulatory development, and product development. Its products are used for treating hepatitis B-virus, diabetic neuropathy, liver damage, seasonal allergies and bronchial asthma. It operates through a research and development center located in Korea. BUKWANG is headquartered in Seoul, South Korea.

Bukwang Pharm Co Ltd (003000) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bukwang Pharma Enters into Partnership with TVM Capital Life Science 10
Licensing Agreements 11
Sumitomo Dainippon Pharma Enters into Licensing Agreement with Bukwang Pharm 11
Melior Pharma Enters Into Licensing Agreement With Bukwang Pharma 12
Acquisition 13
Bukwang Pharma Acquires Contera Pharma 13
Bukwang Pharm Co Ltd - Key Competitors 14
Bukwang Pharm Co Ltd - Key Employees 15
Bukwang Pharm Co Ltd - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables

List of Tables
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bukwang Pharm Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bukwang Pharma Enters into Partnership with TVM Capital Life Science 10
Sumitomo Dainippon Pharma Enters into Licensing Agreement with Bukwang Pharm 11
Melior Pharma Enters Into Licensing Agreement With Bukwang Pharma 12
Bukwang Pharma Acquires Contera Pharma 13
Bukwang Pharm Co Ltd, Key Competitors 14
Bukwang Pharm Co Ltd, Key Employees 15
Bukwang Pharm Co Ltd, Other Locations 16
Bukwang Pharm Co Ltd, Subsidiaries 17

List Of Figures

List of Figures
Genesis Energy LP, Performance Chart (2013 - 2017) 28
Genesis Energy LP, Ratio Charts 30
Genesis Energy LP, Oil & Gas, Deals By Year, 2012 to YTD 2018 31
Genesis Energy LP, Oil & Gas, Deals by Type, 2012 to YTD 2018 41

Bukwang PharmCo, Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Bukwang PharmCo, Ltd Company Profile is a detailed strategic and analytical report on Bukwang PharmCo, Ltd. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200View Report

Bukwang Pharm Co Ltd (003000) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bukwang PharmCo Ltd (BUKWANG) is a pharmaceutical company which develops pharmaceutical products and new drugs. The companys product portfolio includes levovir, legalon, dexid, thioctacid, lonasen, ixel, Orfil, azeptin, asima among

USD 250View Report

Sam Chun Dang Pharm Co Ltd (000250) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Sam Chun Dang Pharm Co Ltd (SCD) is a manufacturer of prescription medicines. The company offers products in the therapeutic areas of ophthalmology, cardiovasculars, endocrinology, gastrointestines, antibacterials, anti-fungals, antivirals, respiratory,

USD 250View Report

TTY Biopharm Company Ltd (4105) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

TTY Biopharm Company Ltd (TTY) is a biopharmaceutical company that develops and markets drugs for cancer, anti-infection and blood vessel diseases. The companys liposome products comprise TOT202 and TOT401. It

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :18
Country :South Korea
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube